Fig. 2.
Downregulation of PAQR5 is positively correlated with worse survival outcomes in ccRCC patients. A Kaplan‒Meier survival curves of OS, DSS, and PFI in 539, 528, and 537 ccRCC patients respectively. Patients were divided into high and low expression groups cutoff by the median expression of PAQR5. B Forest plots for univariate and multivariate Cox regression analysis of overall survival in 539 patients with clear cell renal cell carcinoma with respect to PAQR5 expression and diverse clinicopathological parameters
